'We're looking for anything, because otherwise we don't have much other than high-quality critical care and good medicine,' Dr. Craig Spencer told CNBC.
, said doctors are "grasping at straws," hoping the currently unproven treatments do make a difference for patients with Covid-19.
"In the meantime, we're going to keep using things we think may help but recognizing that they may not make a huge dent in things like mortality, ICU stays and the likelihood people will come off a ventilator," he said.for therapeutics produce "good data" in the coming months. But he emphasized that there is much uncertainty around treatments.
"Do we know if any of these are going to significantly reduce mortality or infection? No. Will there probably be some things that are likely to shorten the length of disease or decrease the likelihood that people get on a ventilator? Probably," he said. However, Spencer also said it is possible studies do not determine that any drugs are highly effective treatments. "And we'll have to continue to rely on good old public health to stop the spread of this disease and prevent this from becoming a much bigger outbreak," he said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Why Did The World Shut Down For COVID-19 But Not Ebola, SARS Or Swine Flu?We’re currently battling a global pandemic unlike any we’ve seen in over a century. But it’s also not the first modern virus we’ve faced.
Read more »
UNICEF USA BrandVoice: Ebola, Measles And Now COVID-19: DR Congo In CrisisEfforts to vanquish deadly Ebola from the Democratic of the Congo have battered the country’s health system, leaving children and families vulnerable to other deadly diseases — old and new.
Read more »
Why Did The World Shut Down For COVID-19 But Not Ebola, SARS Or Swine Flu?We’re currently battling a global pandemic unlike any we’ve seen in over a century. But it’s also not the first modern virus we’ve faced.
Read more »
Doctor explains the complex supply chains holding back testing expansionsDr. Amesh Adalja, a senior scholar at the Johns Hopkins University Center for Health Security, joins Andrea Mitchell to discuss the latest developments on the need to expand testing to reopen the country and the shifting projections on the scope of the disease.
Read more »